Login Register Cart 0
Generic placeholder image

Reviews on Recent Clinical Trials

Editor-in-Chief

ISSN (Print): 1574-8871
ISSN (Online): 1876-1038

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Perspective Article

Management of Idiopathic Intracranial Hypertension During the COVID-19 Pandemic

Author(s): Ayman G. Elnahry* and Gehad A. Elnahry

Volume 16, Issue 2, 2021

Published on: 17 September, 2020

Page: [122 - 125] Pages: 4

DOI: 10.2174/1574887115666200917111413

Abstract

Background: In the current coronavirus disease 2019 (COVID-19) pandemic, health systems are struggling to prioritize care for affected patients; however, physicians globally are also attempting to maintain care for other less-threatening medical conditions that may lead to permanent disabilities if untreated. Idiopathic intracranial hypertension (IIH) is a relatively common condition affecting young females that could lead to permanent blindness if not properly treated. In this article, we provide some insight and recommendations regarding the management of IIH during the pandemic.

Methods: The diagnosis, follow-up, and treatment methods of IIH during the COVID-19 pandemic period are reviewed. COVID-19, as a mimic of IIH, is also discussed.

Results: Diagnosis and follow-up of papilledema due to IIH during the COVID-19 pandemic can be facilitated by nonmydriatic fundus photography and optical coherence tomography. COVID-19 may mimic IIH by presenting as cerebral venous sinus thrombosis, papillophlebitis, or meningoencephalitis, so a high index of suspicion is required in these cases. When surgical treatment is indicated, optic nerve sheath fenestration may be the primary procedure of choice during the pandemic period.

Conclusion: IIH is a serious vision-threatening condition that could lead to permanent blindness and disability at a relatively young age if left untreated. It could be the first presentation of a COVID-19 infection. Certain precautions during the diagnosis and management of this condition could be taken that may allow appropriate care to be delivered to these patients while minimizing the risk of coronavirus infection.

Keywords: COVID-19, idiopathic intracranial hypertension, nonmydriatic fundus photography, optic nerve sheath fenestration, cerebral venous sinus thrombosis, papillophlebitis, meningoencephalitis.

« Previous Next »
Graphical Abstract

[1]
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19).StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK554776/ internet
[2]
Baracchini C, Pieroni A, Viaro F, et al. Acute stroke management pathway during Coronavirus-19 pandemic. Neurol Sci 2020; 41(5): 1003-5.
[http://dx.doi.org/10.1007/s10072-020-04375-9] [PMID: 32270359]
[3]
Caso V, Federico A. No lockdown for neurological diseases during COVID19 pandemic infection. Neurol Sci 2020; 41(5): 999-1001.
[http://dx.doi.org/10.1007/s10072-020-04389-3] [PMID: 32270358]
[4]
Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59(10): 1492-5.
[http://dx.doi.org/10.1212/01.WNL.0000029570.69134.1B] [PMID: 12455560]
[5]
Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia 2006; 26(4): 384-99.
[http://dx.doi.org/10.1111/j.1468-2982.2005.01055.x] [PMID: 16556239]
[6]
Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology 2007; 68(3): 229-32.
[http://dx.doi.org/10.1212/01.wnl.0000251312.19452.ec] [PMID: 17224579]
[7]
Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013; 81(13): 1159-65.
[http://dx.doi.org/10.1212/WNL.0b013e3182a55f17] [PMID: 23966248]
[8]
Bruce BB, Lamirel C, Biousse V, et al. Feasibility of nonmydriatic ocular fundus photography in the emergency department: Phase I of the FOTO-ED study. Acad Emerg Med 2011; 18(9): 928-33.
[http://dx.doi.org/10.1111/j.1553-2712.2011.01147.x] [PMID: 21906202]
[9]
Ko MW, Busis NA. Tele-Neuro-Ophthalmology: Vision for 20/20 and Beyond. J Neuroophthalmol 2020; 40(3): 378-84. [published online ahead of print, 2020 Jun 26]
[http://dx.doi.org/10.1097/WNO.0000000000001038] [PMID: 32604247]
[10]
LaMonica LC, Hawley NL, Bhardwaj MK, Naseri T, Reupena MS, Ramsey DJ. Nonmydriatic fundus photography in a high-risk population of Samoans with diabetes: The Soifua Manuia eye screening program. Clin Exp Ophthalmol 2019; 47(7): 954-6.
[http://dx.doi.org/10.1111/ceo.13527] [PMID: 31034672]
[11]
Shuaib MM, Helmy GM, Badr Eldin N, Elnahry AG, Elnahry GA. Optical coherence tomography of the optic nerve head before and after optic nerve sheath fenestration for idiopathic intracranial hypertension. Acta Neurol Belg 2020; 120(3): 775-7.
[http://dx.doi.org/10.1007/s13760-020-01331-4] [PMID: 32185637]
[12]
Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 2020; 92(6): 589-94.
[http://dx.doi.org/10.1002/jmv.25725] [PMID: 32100876]
[13]
Chwalisz BK, Dinkin MJ. Disease of the Year: COVID-19 and Its Neuro-ophthalmic Complications. J Neuroophthalmol 2020; 40(3): 283-4. [published online ahead of print, 2020 Jun 26
[http://dx.doi.org/10.1097/WNO.0000000000001046] [PMID: 32604246]
[14]
Grossman SN, Calix R, Tow S, et al. Neuro-ophthalmology in the Era of COVID-19: Future Implications of a Public Health Crisis Ophthalmology 2020.
[15]
Milea D, Najjar RP, Zhubo J, et al. BONSAI Group. Artificial Intelligence to Detect Papilledema from Ocular Fundus Photographs. N Engl J Med 2020; 382(18): 1687-95.
[http://dx.doi.org/10.1056/NEJMoa1917130] [PMID: 32286748]
[16]
Prea SM, Kong YXG, Mehta A, et al. Six-month Longitudinal Comparison of a Portable Tablet Perimeter With the Humphrey Field Analyzer. Am J Ophthalmol 2018; 190: 9-16.
[http://dx.doi.org/10.1016/j.ajo.2018.03.009] [PMID: 29550190]
[17]
Hemasian H, Ansari B. First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case. Rev Neurol (Paris) 2020; 176(6): 521-3.
[http://dx.doi.org/10.1016/j.neurol.2020.04.013] [PMID: 32414532]
[18]
Hughes C, Nichols T, Pike M, Subbe C, Elghenzai S. Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19. Eur J Case Rep Intern Med 2020; 7(5): 001691.
[http://dx.doi.org/10.12890/2020_001691] [PMID: 32399457]
[19]
Poillon G, Obadia M, Perrin M, Savatovsky J, Lecler A. Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence? J Neuroradiol 2020.
[20]
Shakibajahromi B, Borhani-Haghighi A, Haseli S, Mowla A. Cerebral venous sinus thrombosis might be under-diagnosed in the COVID-19 era. eNeurologicalSci 2020; 20: 100256.
[http://dx.doi.org/10.1016/j.ensci.2020.100256] [PMID: 32704578]
[21]
Duong L, Xu P, Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav Immun 2020; 87: 33.
[http://dx.doi.org/10.1016/j.bbi.2020.04.024] [PMID: 32305574]
[22]
Mardani M, Nadji SA, Sarhangipor KA, Sharifi-Razavi A, Baziboroun M. COVID-19 infection recurrence presenting with meningoencephalitis. New Microbes New Infect 2020; 37: 100732.
[http://dx.doi.org/10.1016/j.nmni.2020.100732] [PMID: 32789020]
[23]
Ravid S, Shachor-Meyouhas Y, Shahar E, Kra-Oz Z, Kassis I. Viral-induced intracranial hypertension mimicking pseudotumor cerebri. Pediatr Neurol 2013; 49(3): 191-4.
[http://dx.doi.org/10.1016/j.pediatrneurol.2013.03.007] [PMID: 23831246]
[24]
Insausti-García A, Reche-Sainz JA, Ruiz-Arranz C, López Vázquez Á, Ferro-Osuna M. Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state. Eur J Ophthalmol 2020; 1120672120947591: 1120672120947591. [published online ahead of print, 2020 Jul 30
[http://dx.doi.org/10.1177/1120672120947591] [PMID: 32735134]
[25]
Ellenberger C Jr, Messner KH. Papillophlebitis: benign retinopathy resembling papilledema or papillitis. Ann Neurol 1978; 3(5): 438-40.
[http://dx.doi.org/10.1002/ana.410030514] [PMID: 727723]
[26]
Spitze A, Malik A, Al-Zubidi N, Golnik K, Lee AG. Optic nerve sheath fenestration vs cerebrospinal diversion procedures: what is the preferred surgical procedure for the treatment of idiopathic intracranial hypertension failing maximum medical therapy? J Neuroophthalmol 2013; 33(2): 183-8.
[http://dx.doi.org/10.1097/WNO.0b013e318292d06f] [PMID: 23681243]

Rights & Permissions Print Cite
Article Metrics
50
© 2024 Bentham Science Publishers | Privacy Policy